Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $5.4 million.

  • Aspen Aerogels' Depreciation and Depletion rose 188.68% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 373.76%. This contributed to the annual value of $22.5 million for FY2024, which is 4705.58% up from last year.
  • According to the latest figures from Q3 2025, Aspen Aerogels' Depreciation and Depletion is $5.4 million, which was up 188.68% from $5.8 million recorded in Q2 2025.
  • Aspen Aerogels' Depreciation and Depletion's 5-year high stood at $6.0 million during Q2 2024, with a 5-year trough of $2.1 million in Q2 2022.
  • Over the past 5 years, Aspen Aerogels' median Depreciation and Depletion value was $3.5 million (recorded in 2023), while the average stood at $3.9 million.
  • As far as peak fluctuations go, Aspen Aerogels' Depreciation and Depletion tumbled by 1933.28% in 2022, and later skyrocketed by 11449.7% in 2024.
  • Aspen Aerogels' Depreciation and Depletion (Quarter) stood at $2.5 million in 2021, then decreased by 0.71% to $2.5 million in 2022, then soared by 79.14% to $4.5 million in 2023, then increased by 20.1% to $5.4 million in 2024, then decreased by 0.48% to $5.4 million in 2025.
  • Its Depreciation and Depletion stands at $5.4 million for Q3 2025, versus $5.8 million for Q2 2025 and $5.8 million for Q1 2025.